| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 169.76B | 177.65B | 163.27B | 150.36B | 132.43B | 112.07B |
| Gross Profit | 58.45B | 65.08B | 55.18B | 43.84B | 34.98B | 28.51B |
| EBITDA | 36.02B | 39.63B | 33.05B | 24.55B | 17.04B | 12.18B |
| Net Income | 25.12B | 28.40B | 24.15B | 17.31B | 11.73B | 9.21B |
Balance Sheet | ||||||
| Total Assets | 190.39B | 224.87B | 194.40B | 182.70B | 164.85B | 130.51B |
| Cash, Cash Equivalents and Short-Term Investments | 20.57B | 31.05B | 16.75B | 17.64B | 15.56B | 20.20B |
| Total Debt | 28.15B | 34.40B | 22.73B | 36.67B | 33.25B | 15.87B |
| Total Liabilities | 71.01B | 81.90B | 73.20B | 80.55B | 78.48B | 54.50B |
| Stockholders Equity | 119.38B | 142.96B | 120.95B | 101.93B | 86.17B | 75.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 29.37B | 26.54B | 20.50B | -21.18B | 8.29B |
| Operating Cash Flow | 0.00 | 31.44B | 28.80B | 21.69B | -19.98B | 10.79B |
| Investing Cash Flow | 0.00 | -2.74B | -2.13B | -1.42B | -1.31B | -1.52B |
| Financing Cash Flow | 0.00 | 3.12B | -20.82B | -641.00M | 14.71B | -2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥985.46B | 60.50 | 6.61% | 1.58% | -1.47% | -19.46% | |
75 Outperform | ¥251.12B | 18.20 | 9.02% | 3.11% | 9.57% | 40.16% | |
74 Outperform | ¥84.60B | 10.90 | 16.37% | 2.79% | 42.29% | 55.00% | |
73 Outperform | ¥703.48B | 24.82 | ― | 1.43% | 8.81% | 17.58% | |
64 Neutral | ¥143.42B | 15.69 | 12.54% | 1.84% | 17.17% | 33.30% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥227.01B | 20.35 | ― | 2.41% | 5.68% | -49.64% |